A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT07553988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07553988
- Sponsor
- R-Pharm International, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-24
- Primary completion
- 2026-05-14
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.